{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:08:07Z","timestamp":1791925687905,"version":"4.3.4"},"reference-count":86,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T00:00:00Z","timestamp":1639612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014803","name":"European Food Safety Authority","doi-asserted-by":"publisher","award":["CZ.02.1.01\/0.0\/0.0\/16_019\/0000841"],"award-info":[{"award-number":["CZ.02.1.01\/0.0\/0.0\/16_019\/0000841"]}],"id":[{"id":"10.13039\/100014803","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>The utility of clinically available antifungals is limited by their narrow spectrum of activity, high toxicity, and emerging resistance. Antifungal drug discovery has always been a challenging area, since fungi and their human host are eukaryotes, making it difficult to identify unique targets for antifungals. Novel antifungals in clinical development include first-in-class agents, new structures for an established target, and formulation modifications to marketed antifungals, in addition to repurposed agents. Membrane interacting peptides and aromatherapy are gaining increased attention in the field. Immunotherapy is another promising treatment option, with antifungal antibodies advancing into clinical trials. Novel targets for antifungal therapy are also being discovered, allowing the design of new promising agents that may overcome the resistance issue. In this mini review, we will summarize the current status of antifungal drug pipelines in clinical stages, and the most recent advancements in preclinical antifungal drug development, with special focus on their chemistry.<\/jats:p>","DOI":"10.3390\/ph14121312","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T21:32:40Z","timestamp":1639690360000},"page":"1312","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":123,"title":["Advances in Antifungal Drug Development: An Up-To-Date Mini Review"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2024-5788","authenticated-orcid":false,"given":"Ghada","family":"Bouz","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy in Hradec Kr\u00e1lov\u00e9, Charles University, 50005 Hradec Kr\u00e1lov\u00e9, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1558-6625","authenticated-orcid":false,"given":"Martin","family":"Dole\u017eal","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy in Hradec Kr\u00e1lov\u00e9, Charles University, 50005 Hradec Kr\u00e1lov\u00e9, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,12,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.3201\/eid2611.203504","article-title":"Multidrug-Resistant Candida auris Infections in Critically Ill Coronavirus Disease Patients, India, April\u2013July 2020","volume":"26","author":"Chowdhary","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.fgb.2017.10.008","article-title":"Overview of selected virulence attributes in Aspergillus fumigants, Candida albicans, Cryptococcus neoformans, Trichophyton rubrum, and Exophiala dermatitidis","volume":"111","author":"Boral","year":"2018","journal-title":"Fungal Genet. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Du, H., Bing, J., Hu, T.R., Ennis, C.L., Nobile, C.J., and Huang, G.H. (2020). Candida auris: Epidemiology, biology, antifungal resistance, and virulence. PLoS Pathog., 16.","DOI":"10.1371\/journal.ppat.1008921"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0966-842X(03)00117-3","article-title":"Antifungal agents: Mechanisms of action","volume":"11","author":"Odds","year":"2003","journal-title":"Trends Microbiol."},{"key":"ref_5","first-page":"CD003940","article-title":"Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children","volume":"2010","author":"Pienaar","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/jac\/46.2.171","article-title":"Flucytosine: A review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions","volume":"46","author":"Vermes","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1007\/s00253-013-4761-9","article-title":"Echinocandins: Production and applications","volume":"97","author":"Emri","year":"2013","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1128\/AAC.49.7.2851-2856.2005","article-title":"Cryptococcus neoformans resistance to echinocandins: (1,3)beta-glucan synthase activity is sensitive to echinocandins","volume":"49","author":"Maligie","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/1091581814545245","article-title":"Tavaborole, a novel boron-containing small molecule for the topical treatment of onychomycosis, is noncarcinogenic in 2-year carcinogenicity studies","volume":"33","author":"Ciaravino","year":"2014","journal-title":"Int. J. Toxicol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/jac\/dkw095","article-title":"T-2307, a novel arylamidine, is transported into Candida albicans nby a high-affinity spermine and spermidine carrier regulated by Agp2","volume":"71","author":"Nishikawa","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1128\/AAC.00355-10","article-title":"T-2307 Shows Efficacy in a Murine Model of Candida glabrata Infection despite In Vitro Trailing Growth Phenomena","volume":"54","author":"Yamada","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Wiederhold, N.P. (2021). Review of T-2307, an Investigational Agent That Causes Collapse of Fungal Mitochondrial Membrane Potential. J. Fungi, 7.","DOI":"10.3390\/jof7020130"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1021\/id5000212","article-title":"Chemical Genomics-Based Antifungal Drug Discovery: Targeting Glycosylphosphatidylinositol (GPI) Precursor Biosynthesis","volume":"1","author":"Mann","year":"2015","journal-title":"ACS Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1016\/j.bmcl.2010.06.005","article-title":"Synthesis and evaluation of novel antifungal agents-quinoline and pyridine amide derivatives","volume":"20","author":"Nakamoto","year":"2010","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1128\/AAC.00731-11","article-title":"E1210, a new broad-spectrum antifungal, suppresses Candida albicans hyphal growth through inhibition of glycosylphosphatidylinositol biosynthesis","volume":"56","author":"Watanabe","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Shaw, K.J., and Ibrahim, A.S. (2020). Fosmanogepix: A Review of the First-in-Class Broad Spectrum Agent for the Treatment of Invasive Fungal Infections. J. Fungi, 6.","DOI":"10.3390\/jof6040239"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1128\/jb.154.1.488-498.1983","article-title":"Inhibition of Chitin Synthesis in the Cell-Wall of Coccidioides-Immitis by Polyoxin-D","volume":"154","author":"Hector","year":"1983","journal-title":"J. Bacteriol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1128\/AAC.01154-08","article-title":"Differential Effects of Inhibiting Chitin and 1,3-beta-D-Glucan Synthesis in Ras and Calcineurin Mutants of Aspergillus fumigatus","volume":"53","author":"Fortwendel","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Larwood, D.J. (2020). Nikkomycin Z-Ready to Meet the Promise?. J. Fungi, 6.","DOI":"10.3390\/jof6040261"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"12809","DOI":"10.1073\/pnas.1608304113","article-title":"F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase","volume":"113","author":"Oliver","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/infdis\/jix479","article-title":"Pharmacodynamics of the Novel Antifungal Agent F901318 for Acute Sinopulmonary Aspergillosis Caused by Aspergillus flavus","volume":"217","author":"Negri","year":"2018","journal-title":"J. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Wiederhold, N.P. (2020). Review of the Novel Investigational Antifungal Olorofim. J. Fungi, 6.","DOI":"10.3390\/jof6030122"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/ja.2016.106","article-title":"Discovery of a new antifungal agent ASP2397 using a silkworm model of Aspergillus fumigatus infection","volume":"70","author":"Nakamura","year":"2017","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e02689-18","DOI":"10.1128\/AAC.02689-18","article-title":"ASP2397 Is a Novel Natural Compound That Exhibits Rapid and Potent Fungicidal Activity against Aspergillus Species through a Specific Transporter","volume":"63","author":"Nakamura","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"925","DOI":"10.7164\/antibiotics.44.925","article-title":"Structure of aureobasidin A","volume":"44","author":"Ikai","year":"1991","journal-title":"J. Antibiot."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1017\/S0031182017000877","article-title":"The antifungal Aureobasidin A and an analogue are active against the protozoan parasite Toxoplasma gondii but do not inhibit sphingolipid biosynthesis\u2014Corrigendum","volume":"145","author":"Alqaisi","year":"2018","journal-title":"Parasitology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"359","DOI":"10.7164\/antibiotics.51.359","article-title":"Syntheses of antifungal aureobasidin A analogs with alkyl chains for structure-activity relationship","volume":"51","author":"Kurome","year":"1998","journal-title":"J. Antibiot."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1128\/JCM.00618-09","article-title":"Activity of MGCD290, a Hos2 Histone Deacetylase Inhibitor, in Combination with Azole Antifungals against Opportunistic Fungal Pathogens","volume":"47","author":"Pfaller","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.mib.2013.03.005","article-title":"The fungal Achilles\u2019 heel: Targeting Hsp90 to cripple fungal pathogens","volume":"16","author":"Cowen","year":"2013","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.diagmicrobio.2014.11.008","article-title":"In vitro activity of a Hos2 deacetylase inhibitor, MGCD290, in combination with echinocandins against echinocandin-resistant Candida species","volume":"81","author":"Pfaller","year":"2015","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1016\/j.bmcl.2014.05.068","article-title":"Design and optimization of highly-selective fungal CYP51 inhibitors","volume":"24","author":"Hoekstra","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3389\/fmicb.2019.00691","article-title":"The Fungal CYP51s: Their Functions, Structures, Related Drug Resistance, and Inhibitors","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.1128\/AAC.00349-16","article-title":"The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human Enzyme","volume":"60","author":"Warrilow","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.1128\/AAC.00185-15","article-title":"Efficacy of the Clinical Agent VT-1161 against Fluconazole-Sensitive and -Resistant Candida albicans in a Murine Model of Vaginal Candidiasis","volume":"59","author":"Garvey","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e02233-18","DOI":"10.1128\/AAC.02233-18","article-title":"The Fungal Cyp51-Specific Inhibitor VT-1598 Demonstrates In Vitro and In Vivo Activity against Candida auris","volume":"63","author":"Wiederhold","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1128\/AAC.46.9.3001-3012.2002","article-title":"The antifungal echinocandin caspofungin acetate kills growing cells of Aspergillus fumigatus in vitro","volume":"46","author":"Bowman","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_37","first-page":"766","article-title":"Drug evaluation: BAL-8557\u2014A novel broad-spectrum triazole antifungal","volume":"7","author":"Odds","year":"2006","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1128\/AAC.50.1.279-285.2006","article-title":"Single-ascending-dose pharmacokinetics and safety of the novel broad-spectrum antifungal triazole BAL4815 after intravenous infusions (50, 100, and 200 milligrams) and oral administrations (100, 200, and 400 milligrams) of its prodrug, BAL8557, in healthy volunteers","volume":"50","author":"Roos","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1021\/jm970726e","article-title":"New azole antifungals. 2. Synthesis and antifungal activity of heterocyclecarboxamide derivatives of 3-amino-2-aryl-1-azolyl-2-butanol","volume":"41","author":"Bartroli","year":"1998","journal-title":"J. Med. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijantimicag.2012.10.020","article-title":"In vivo pharmacokinetics and in vitro antifungal activity of iodiconazole, a new triazole, determined by microdialysis sampling","volume":"41","author":"Sun","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"6636","DOI":"10.1128\/AEM.05780-11","article-title":"New nystatin-related antifungal polyene macrolides with altered polyol region generated via biosynthetic engineering of Streptomyces noursei","volume":"77","author":"Brautaset","year":"2011","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ja.2016.89","article-title":"CD101, a novel echinocandin with exceptional stability properties and enhanced aqueous solubility","volume":"70","author":"Krishnan","year":"2017","journal-title":"J. Antibiot."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e01626-16","DOI":"10.1128\/AAC.01626-16","article-title":"Pharmacokinetics of the Novel Echinocandin CD101 in Multiple Animal Species","volume":"61","author":"Ong","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e01009-17","DOI":"10.1128\/AAC.01009-17","article-title":"Unraveling Drug Penetration of Echinocandin Antifungals at the Site of Infection in an Intra-abdominal Abscess Model","volume":"61","author":"Zhao","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.1128\/AAC.00973-15","article-title":"Population Pharmacokinetic Modeling of Itraconazole and Hydroxyitraconazole for Oral SUBA-Itraconazole and Sporanox Capsule Formulations in Healthy Subjects in Fed and Fasted States","volume":"59","author":"Abuhelwa","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jaad.2020.06.055","article-title":"Efficacy and safety of topical terbinafine 10% solution (MOB-015) in the treatment of mild to moderate distal subungual onychomycosis: A randomized, multicenter, double-blind, vehicle-controlled phase 3 study","volume":"85","author":"Gupta","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1097\/ICO.0000000000002375","article-title":"In Vitro Antimicrobial Activity of a New Ophthalmic Solution Containing Hexamidine Diisethionate 0.05% (Keratosept)","volume":"39","author":"Pinna","year":"2020","journal-title":"Cornea"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"E178","DOI":"10.1111\/aos.14243","article-title":"In vitro antimicrobial activity of a new ophthalmic solution containing povidone-iodine 0.6% (IODIM (R))","volume":"98","author":"Pinna","year":"2020","journal-title":"Acta Ophthalmol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1128\/AAC.44.9.2356-2360.2000","article-title":"Efficacy of oral cochleate-amphotericin B in a mouse model of systemic candidiasis","volume":"44","author":"Santangelo","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cbpa.2012.01.013","article-title":"The potential of organometallic complexes in medicinal chemistry","volume":"16","author":"Gasser","year":"2012","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1021\/om401096y","article-title":"Synthesis and Biological Evaluation of Organoruthenium Complexes with Azole Antifungal Agents. First Crystal Structure of a Tioconazole Metal Complex","volume":"33","author":"Kljun","year":"2014","journal-title":"Organometallics"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Stevanovi\u0107, N.L., Aleksic, I., Kljun, J., Bogojevic, S.S., Veselinovic, A., Nikodinovic-Runic, J., Turel, I., Djuran, M.I., and Gli\u0161i\u0107, B.\u0110. (2021). Copper(II) and Zinc(II) Complexes with the Clinically Used Fluconazole: Comparison of Antifungal Activity and Therapeutic Potential. Pharmaceuticals, 14.","DOI":"10.3390\/ph14010024"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1039\/D0DT04061D","article-title":"Tailoring copper(II) complexes with pyridine-4,5-dicarboxylate esters for anti-Candida activity","volume":"50","author":"Aleksic","year":"2021","journal-title":"Dalton Trans."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.ejmech.2018.07.049","article-title":"Mononuclear silver(I) complexes with 1,7-phenanthroline as potent inhibitors of Candida growth","volume":"156","author":"Savic","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Polvi, E.J., Averette, A.F., Lee, S.C., Kim, T., Bahn, Y., Veri, A.O., Robbins, N., Heitman, J., and Cowen, L.E. (2016). Metal Chelation as a Powerful Strategy to Probe Cellular Circuitry Governing Fungal Drug Resistance and Morphogenesis. PLoS Genet., 12.","DOI":"10.1371\/journal.pgen.1006350"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"10346","DOI":"10.1039\/D0CS00945H","article-title":"Recent developments of metal-based compounds against fungal pathogens","volume":"50","author":"Lin","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1093\/jac\/dkx020","article-title":"In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: An emerging fungal pathogen","volume":"72","author":"Nishikawa","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jpba.2009.07.016","article-title":"An ultra-fast LC method for the determination of iodiconazole in microdialysis samples and its application in the calibration of laboratory-made linear probes","volume":"51","author":"Sun","year":"2010","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1021\/acs.jnatprod.1c00116","article-title":"Synthesis and Antifungal Activity Evaluation of Phloeodictine Analogues","volume":"84","author":"Ravu","year":"2021","journal-title":"J. Nat. Prod."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"15912","DOI":"10.1021\/acs.jmedchem.1c01299","article-title":"Optimization and Evaluation of Novel Antifungal Agents for the Treatment of Fungal Infection","volume":"64","author":"Choi","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"10482","DOI":"10.1021\/acs.jmedchem.1c00883","article-title":"Identification of Thiazoyl Guanidine Derivatives as Novel Antifungal Agents Inhibiting Ergosterol Biosynthesis for Treatment of Invasive Fungal Infections","volume":"64","author":"Kato","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1021\/acs.jmedchem.0c01763","article-title":"Novel Carboline Fungal Histone Deacetylase (HDAC) Inhibitors for Combinational Treatment of Azole-Resistant Candidiasis","volume":"64","author":"Li","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1099\/mic.0.27029-0","article-title":"Dosage-dependent functions of fatty acid desaturase Ole1p in growth and morphogenesis of Candida albicans","volume":"150","author":"Krishnamurthy","year":"2004","journal-title":"Microbiology-Sgm"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1021\/acsinfecdis.1c00404","article-title":"Identification of Inhibitors of Fungal Fatty Acid Biosynthesis","volume":"7","author":"DeJarnette","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1021\/acsinfecdis.1c00270","article-title":"Identification of Dual-Target Compounds with Anti-fungal and Anti-NLRP3 Inflammasome Activity","volume":"7","author":"Lowes","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"740","DOI":"10.2174\/13816128113199990009","article-title":"Acetohydroxyacid Synthase: A Target for Antimicrobial Drug Discovery","volume":"20","author":"Pue","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Camilli, G., Griffiths, J.S., Ho, J., Richardson, J.P., and Naglik, J.R. (2020). Some like it hot: Candida activation of inflammasomes. PLoS Pathog., 16.","DOI":"10.1371\/journal.ppat.1008975"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.plipres.2011.12.005","article-title":"Role of lipids in the interaction of antimicrobial peptides with membranes","volume":"51","author":"Teixeira","year":"2012","journal-title":"Prog. Lipid Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.biotechadv.2018.01.004","article-title":"Designing improved active peptides for therapeutic approaches against infectious diseases","volume":"36","author":"Gomes","year":"2018","journal-title":"Biotechnol. Adv."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"649875","DOI":"10.3389\/fcell.2021.649875","article-title":"Membrane-Interacting Antifungal Peptides","volume":"9","author":"Struyfs","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Donadu, M.G., Peralta-Ruiz, Y., Usai, D., Maggio, F., Molina-Hernandez, J.B., Rizzo, D., Bussu, F., Rubino, S., Zanetti, S., and Paparella, A. (2021). Colombian Essential Oil of Ruta graveolens against Nosocomial Antifungal Resistant Candida Strains. J. Fungi, 7.","DOI":"10.3390\/jof7050383"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1080\/14786419.2018.1557175","article-title":"Antifungal activity of oils macerates of North Sardinia plants against Candida species isolated from clinical patients with candidiasis","volume":"34","author":"Donadu","year":"2020","journal-title":"Nat. Prod. Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1080\/14786419.2017.1385014","article-title":"Antimicrobial activity of Austroeupatorium inulaefolium (HBK) against intracellular and extracellular organisms","volume":"32","author":"Bua","year":"2018","journal-title":"Nat. Prod. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1128\/AAC.01564-08","article-title":"Antifungal Activity of Tamoxifen: In Vitro and In Vivo Activities and Mechanistic Characterization","volume":"53","author":"Dolan","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"7115","DOI":"10.1128\/AAC.01061-16","article-title":"The Celecoxib Derivative AR-12 Has Broad-Spectrum Antifungal Activity In Vitro and Improves the Activity of Fluconazole in a Murine Model of Cryptococcosis","volume":"60","author":"Koselny","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s40588-020-00141-9","article-title":"Immunotherapy as an Antifungal Strategy in Immune Compromised Hosts","volume":"7","author":"Posch","year":"2020","journal-title":"Curr. Clin. Microbiol. Rep."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1128\/IAI.00278-07","article-title":"An anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neofonnans in vitro and exerts therapeutic, anticryptococcal activity in vivo","volume":"75","author":"Rachini","year":"2007","journal-title":"Infect. Immun."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"19500","DOI":"10.1038\/s41598-021-98659-5","article-title":"A new humanized antibody is effective against pathogenic fungi in vitro","volume":"11","author":"Mambro","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_79","first-page":"283","article-title":"Radioimmunotherapy of fungal diseases: The therapeutic potential of cytocidal radiation delivered by antibody targeting fungal cell surface antigens","volume":"3","author":"Nosanchuk","year":"2012","journal-title":"Front. Microbiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1128\/IAI.74.1.28-39.2006","article-title":"Role of sphingolipids in microbial pathogenesis","volume":"74","author":"Heung","year":"2006","journal-title":"Infect. Immun."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0014-5793(02)03144-7","article-title":"Disruption of the glucosylceramide biosynthetic pathway in Aspergillus nidulans and Aspergillus fumigatus by inhibitors of UDP-Glc: Ceramide glucosyltransferase strongly affects spore germination, cell cycle, and hyphal growth (vol 525, pg 59, 2002)","volume":"526","author":"Levery","year":"2002","journal-title":"Febs Lett."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1172\/JCI27890","article-title":"Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformans","volume":"116","author":"Rittershaus","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"349","DOI":"10.7164\/antibiotics.48.349","article-title":"The Discovery of Australifungin, a Novel Inhibitor of Sphinganine N-Acyltransferase from Sporormiella-Australis\u2014Producing Organism, Fermentation, Isolation, and Biological-Activity","volume":"48","author":"Mandala","year":"1995","journal-title":"J. Antibiot."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1749-6632.1988.tb40396.x","article-title":"The galbonolides. Novel, powerful antifungal macrolides from Streptomyces galbus ssp. eurythermus","volume":"544","author":"Achenbach","year":"1988","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e00647-15","DOI":"10.1128\/mBio.00647-15","article-title":"Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids","volume":"6","author":"Mora","year":"2015","journal-title":"Mbio"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"6706","DOI":"10.1021\/acs.jmedchem.0c02177","article-title":"Re-emerging Aspartic Protease Targets: Examining Cryptococcus neoformans Major Aspartyl Peptidase 1 as a Target for Antifungal Drug Discovery","volume":"64","author":"Brynda","year":"2021","journal-title":"J. Med. Chem."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/14\/12\/1312\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:49:16Z","timestamp":1760168956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/14\/12\/1312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,16]]},"references-count":86,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["ph14121312"],"URL":"https:\/\/doi.org\/10.3390\/ph14121312","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,16]]}}}